Acadian Asset Management
TARA icon

Acadian Asset Management’s Protara Therapeutics TARA Stock Holding History

Acadian Asset Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,314
Closed -$25K – 1901
2024
Q1 		$25K Hold
6,314
– – ﹤0.01% 1465
2023
Q4 		$11K Hold
6,314
– – ﹤0.01% 1620
2023
Q3 		$10K Hold
6,314
– – ﹤0.01% 1592
2023
Q2 		$15K Hold
6,314
– – ﹤0.01% 1665
2023
Q1 		$19K Hold
6,314
– – ﹤0.01% 1659
2022
Q4 		$16K Hold
6,314
– – ﹤0.01% 1724
2022
Q3 		$18K Hold
6,314
– – ﹤0.01% 1608
2022
Q2 		$19K Sell
6,314
-5,416
-46% -$19.8K ﹤0.01% 1620
2022
Q1 		$59K Sell
11,730
-5,489
-32% -$28.9K ﹤0.01% 1448
2021
Q4 		$115K Buy
+17,219
New +$119K ﹤0.01% 1346
2018
Q4 		– Sell
-133
Closed -$10K – 1829
2018
Q3 		$10K Hold
133
– – ﹤0.01% 1553
2018
Q2 		$13K Hold
133
– – ﹤0.01% 1562
2018
Q1 		$13K Hold
133
– – ﹤0.01% 1531
2017
Q4 		$10K Sell
133
-42
-24% -$3.37K ﹤0.01% 1424
2017
Q3 		$14K Sell
175
-37
-17% -$2.12K ﹤0.01% 1255
2017
Q2 		$13K Hold
212
– – ﹤0.01% 1300
2017
Q1 		$15K Buy
+212
New +$15.8K ﹤0.01% 1404

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Acadian Asset Management's TARA Position: Q2 2024 in Review

Acadian Asset Management sold out of Protara Therapeutics (TARA) in Q2 2024, closing a stake of 6,314 shares — an estimated $25K sold.

Acadian Asset Management first reported a position in TARA in Q1 2017 and held it in 17 quarters. The position peaked at $115K in Q4 2021. 38 funds tracked by Wall St. Rank hold TARA as of Q2 2024.

  • Acadian Asset Management reported no remaining Protara Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Acadian Asset Management sold 6,314 Protara Therapeutics shares in Q2 2024, an estimated $25K.
  • Acadian Asset Management first reported a position in Protara Therapeutics in Q1 2017 and held it in 17 quarters.
  • Acadian Asset Management's Protara Therapeutics position peaked at $115K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.